> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel Meeting to Review Glucose Monitor
- URL: https://www.fdaweb.com/panel-meeting-to-review-glucose-monitor/
- Published: 2018-02-28T12:00:00.000Z
- Updated: 2026-09-14T23:26:10.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140864

*Federal Register* notice: FDA has announced a 3/29-30 Clinical Chemistry and Clinical Toxicology Devices Panel meeting. On 3/29, the committee will discuss and vote on a Senseonics PMA for the Eversense CGM System, a continuous glucose monitoring device. On 3/30, the committee will discuss measuring blood glucose using capillary blood with blood glucose meters in all hospital patients, including those receiving intensive medical intervention/therapy and patients with decreased peripheral blood flow, such as with severe hypotension, shock, hyperosmolar-hyperglycemia and severede hydration (e.g., patients in intensive care settings). To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-04167.pdf?ref=fdaweb.com).